JOURNAL ARTICLE
MULTICENTER STUDY
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Increased incidence of respiratory symptoms among female woodworkers exposed to dry wood.

The aim of the present study was to investigate the occurrence of new respiratory symptoms in relation to wood dust exposure in a 6-yr follow-up study. A total of 1,377 woodworkers (1,137 males; 240 females) and 297 reference workers (137 males; 160 females) participated. Data on respiratory symptoms, employment and smoking habits were collected. Wood dust exposure was assessed from baseline dust measurements, and cumulative wood dust exposure was assessed by study-specific job exposure matrices and exposure time. The geometric mean (geometric sd) dust level decreased during the study period from 0.94 (2.1) to 0.60 (1.6) mg.m(-3). Adjusted analysis revealed positive associations for cumulative incidence proportion of chronic bronchitis and daily coughing for female woodworkers versus female reference workers. The cumulative incidence proportion of daily coughing and chronic bronchitis were found to be associated with baseline wood dust exposure in a dose-dependent manner. The odds ratio (95% confidence interval) for daily coughing (with reference to the lowest exposure quartile) was 1.6 (0.6-4.3), 3.2 (0.9-6.8) and 3.8 (1.5-9.7), respectively, in the second and third lowest and the highest quartile. The figures for chronic bronchitis were, accordingly, 2.3 (0.4-14.5), 3.0 (0.5-18.7) and 6.0 (1.2-28.8). In conclusion, female woodworkers in this low exposure cohort showed an increased incidence of coughing and bronchitis, whereas no relations to wood dust exposure were seen for male woodworkers.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app